Synapse - Works

Results (5608)

Potential impact of avelumab + axitinib (A + Ax) on tumor size (TS) compared with historical data of sunitinib (S) as evaluated by a modeling and simulation (MS) approach

Meeting Abstract

Zheng, J.; Chang, A.; Larkin, J.; Motzer, R. J.; Amantea, M.; Bello, C.; Pavlov, D.; Geraldes, M.; Martignoni, M.; Di Pietro, A.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Efficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update

Meeting Abstract

Wong, D. J.; Schneider, J. G.; Aljumaily, R.; Korn, M. W.; Autio, K.; Infante, J. R.; Patel, M. R.; Papadopoulos, K.; Naing, A.; Gabrail, N.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial

Meeting Abstract

Staehler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Kliment, J.; Pantuck, A. J.; Patel, A.; Deannuntis, L.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Phenotypic circulating tumor cell (CTC) classifier of genomic instability (GI) associates with improved overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving platinum agents in addition to taxanes

Meeting Abstract

Scher, H.; Graf, R. P.; Jendrisak, A.; McLaughlin, B.; Barnett, E.; Schreiber, N. A.; Lee, J.; Kelvin, J.; Wang, Y.; Landers, M.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator's choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)

Meeting Abstract

Petrylak, D.; Vogelzang, N. J.; Fradet, Y.; Bajorin, D.; de Wit, R.; Vaughn, D. J.; Lee, J. L.; Fong, L.; Climent, M. A.; Necchi, A.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Powles, T.; McDermott, D. F.; Rini, B.; Motzer, R. J.; Atkins, M. B.; Fong, L.; Joseph, R. W.; Pal, S. K.; Ravaud, A.; Bracarda, S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib (c) vs everolimus (e) in advanced renal cell carcinoma (rcc)

Meeting Abstract

Powles, T.; Motzer, R. J.; George, D. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Mai, T. H.; Scheffold, C.; Wang, E.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Sequential chemo-chemoradiation (CCRT) in locally advanced pancreas cancer in an Irish high volume centre

Meeting Abstract

Abdul Rahman, R.; Teo, M. Y.; Moriarty, M.; McDermott, R.; McVey, G.
Annals of Oncology (2017)

Fulltext@MSK | Save

Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)

Meeting Abstract

Morris, M.; Vogelzang, N. J.; Sartor, O.; Armour, A.; Groaning, M.; Messmann, R.; Robarts, A.; Petrylak, D. P.; Tolcher, A.; Gordon, M. S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population

Meeting Abstract

Necchi, A.; Pond, G. R.; Pal, S. K.; Agarwal, N.; Bowles, D.; Plimack, E.; Yu, E. Y.; Ladoire, S.; Baniel, J.; Crabb, S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save